Pace of FDA research frustrates CBD advocates

By Alex Halperin
Jan 13, 2021
A January article co-authored by U.S. Food and Drug Administration commissioner Stephen Hahn, which calls for more high-quality CBD research, is unlikely to impress many in the hemp industry. CBD advocates have long been frustrated by what they consider the...

This content is FREE for registered users.

To view this content you need to register as a Weedweek member.

If you are already a member please login below.